ATE286739T1 - Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme - Google Patents

Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme

Info

Publication number
ATE286739T1
ATE286739T1 AT01961556T AT01961556T ATE286739T1 AT E286739 T1 ATE286739 T1 AT E286739T1 AT 01961556 T AT01961556 T AT 01961556T AT 01961556 T AT01961556 T AT 01961556T AT E286739 T1 ATE286739 T1 AT E286739T1
Authority
AT
Austria
Prior art keywords
compound containing
weight gain
treat disease
pollen extract
related weight
Prior art date
Application number
AT01961556T
Other languages
English (en)
Inventor
Kaj Winter
Christer Hedman
Lars Kaernerud
Original Assignee
Natumin Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natumin Pharma Ab filed Critical Natumin Pharma Ab
Application granted granted Critical
Publication of ATE286739T1 publication Critical patent/ATE286739T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Medical Informatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Animal Husbandry (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
AT01961556T 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme ATE286739T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0003092A SE0003092D0 (sv) 2000-09-01 2000-09-01 New Use
PCT/SE2001/001850 WO2002017943A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain

Publications (1)

Publication Number Publication Date
ATE286739T1 true ATE286739T1 (de) 2005-01-15

Family

ID=20280860

Family Applications (5)

Application Number Title Priority Date Filing Date
AT01961556T ATE286739T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
AT01963652T ATE283061T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen
AT01961554T ATE283058T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
AT01961557T ATE283060T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen
AT01961555T ATE283059T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit

Family Applications After (4)

Application Number Title Priority Date Filing Date
AT01963652T ATE283061T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen
AT01961554T ATE283058T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
AT01961557T ATE283060T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen
AT01961555T ATE283059T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit

Country Status (10)

Country Link
EP (5) EP1313495B1 (de)
JP (5) JP2004507507A (de)
AT (5) ATE286739T1 (de)
AU (7) AU2001282815A1 (de)
CA (5) CA2424026A1 (de)
DE (5) DE60107443D1 (de)
NO (1) NO330691B1 (de)
PL (1) PL202468B1 (de)
SE (1) SE0003092D0 (de)
WO (5) WO2002017941A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005139150A (ja) * 2003-11-10 2005-06-02 Api Co Ltd エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び飲食品
US7887851B2 (en) 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
CN104027100A (zh) * 2014-06-12 2014-09-10 山东中弘信息科技有限公司 一种基于最近历史值的血压异常数据处理方法
KR101533197B1 (ko) * 2014-09-18 2015-07-02 성균관대학교산학협력단 부테인을 포함하는 부종의 예방 또는 치료용 조성물
FR3055215B1 (fr) * 2016-08-31 2020-02-14 S.A.M. Serelys Pharma Composition comprenant des extraits de pollen et /ou de pistils
CN106138856A (zh) * 2016-09-30 2016-11-23 四川易创生物科技有限公司 一种治疗经间期出血的新型中药组合物及制备方法
EP3335717A1 (de) * 2016-12-13 2018-06-20 Serelys Pharma S.A.M. Zusammensetzung zur verwendung bei der behandlung von symptomen im zusammenhang mit prämenstruellem syndrom (pms)
FR3070263B1 (fr) 2017-08-28 2020-07-24 Serelys Pharma S A M Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2970957B2 (ja) * 1991-05-15 1999-11-02 株式会社グレイトチレン 精製花粉栄養調整物
ES2081255B1 (es) * 1994-01-05 1996-09-01 Ind Farma Especial Aplicacion de las proteinas receptoras de autoincompatibilidad (slsg) de plantas para el tratamiento de las enfermedades alergicas.
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH09278665A (ja) * 1996-04-10 1997-10-28 Api Kk 花粉エキスソフトカプセル剤及びその製造方法
CA2320368C (en) * 1998-02-23 2007-08-21 Taiyo Kagaku Co., Ltd. Composition comprising theanine

Also Published As

Publication number Publication date
DE60107443D1 (de) 2004-12-30
DE60108402D1 (de) 2005-02-17
SE0003092D0 (sv) 2000-09-01
EP1313496B1 (de) 2004-11-24
DE60107441D1 (de) 2004-12-30
JP2004507510A (ja) 2004-03-11
WO2002017940A1 (en) 2002-03-07
AU2001282814B2 (en) 2006-12-21
CA2420906A1 (en) 2002-03-07
JP2004507508A (ja) 2004-03-11
PL360652A1 (en) 2004-09-20
EP1313492B1 (de) 2004-11-24
EP1313496A1 (de) 2003-05-28
JP2004507509A (ja) 2004-03-11
EP1313493B1 (de) 2004-11-24
ATE283059T1 (de) 2004-12-15
AU2001282815A1 (en) 2002-03-13
JP2004507506A (ja) 2004-03-11
ATE283058T1 (de) 2004-12-15
ATE283061T1 (de) 2004-12-15
EP1313495A1 (de) 2003-05-28
EP1313492A1 (de) 2003-05-28
DE60107442D1 (de) 2004-12-30
DE60107444D1 (de) 2004-12-30
NO330691B1 (no) 2011-06-14
AU8281401A (en) 2002-03-13
CA2424026A1 (en) 2002-03-07
NO20030988L (no) 2003-03-03
WO2002017941A1 (en) 2002-03-07
WO2002017944A1 (en) 2002-03-07
CA2420906C (en) 2014-07-15
CA2424011A1 (en) 2002-03-07
AU8458101A (en) 2002-03-13
PL202468B1 (pl) 2009-06-30
CA2420823A1 (en) 2002-03-07
AU2001282816A1 (en) 2002-03-13
AU2001282813A1 (en) 2002-03-13
CA2420823C (en) 2014-07-15
WO2002017942A1 (en) 2002-03-07
NO20030988D0 (no) 2003-03-03
DE60107444T2 (de) 2005-12-08
AU2001284581B2 (en) 2006-09-21
WO2002017943A1 (en) 2002-03-07
JP2004507507A (ja) 2004-03-11
EP1313494B1 (de) 2005-01-12
ATE283060T1 (de) 2004-12-15
EP1313495B1 (de) 2004-11-24
CA2424146A1 (en) 2002-03-07
EP1313493A1 (de) 2003-05-28
JP4896354B2 (ja) 2012-03-14
EP1313494A1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
EP0249735A3 (de) Als aktives Mittel 2-Phenyl-1,2-benzisoselenazol-3(2H)-on enthaltende pharmazeutische Zubereitungen zur Behandlung von durch oxidativen Stress verursachten Krankheiten
WO2002092028A3 (en) Oral care compositions
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
DK0969843T3 (da) Antitussive formuleringer indeholdende theobromin
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
ATE284996T1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
ATE286739T1 (de) Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
ATE324112T1 (de) Topische behandlung bei der mastalgie
TR200100637T2 (tr) Yeni doğal ürün türevleri
DK1343472T3 (da) Thixotropisk næsespray
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
MD1473F2 (en) Antiherpetic remedy
IT8222873A0 (it) Composti steroidei ad attivita'coleretica, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo.
JPS568324A (en) Infectious disease remedy for external and ophthalmologic application
YU75002A (sh) Lokalna antioksidantna vitaminska smeša za negu kože
UA40495A (uk) Склад для лікування захворювань ясен
WO2000002578A8 (fr) Remedes contre les maladies liees a l'apoptose
IE780730L (en) Veterinary composition
MD837G2 (ro) Unguent antimicrobian
UA37377A (uk) Спосіб отримання мазі для лікування захворювань, які викликані внутрішньоклітинними інфекційними агентами
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA
MD2230G2 (ro) Unguent sulfurat
UA36030A (uk) Препарат для лікування і профілактики респіраторних хвороб коней " сегп "

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties